Patents by Inventor Michael Rowley

Michael Rowley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060202186
    Abstract: A fence system including a fence member and a fence rail having a first surface with a first slot and a second surface above the first surface and having a second slot aligned with the first slot. The fence member is inserted through the first slot and the second slot.
    Type: Application
    Filed: January 18, 2006
    Publication date: September 14, 2006
    Inventors: Michael Rowley, David Kurth
  • Publication number: 20060131552
    Abstract: An improved method and apparatus for fencing and other outdoor structures that allow the structure to be changed or adjusted to modify the function, use or appearance of the structure. The structure can be adjusted into a selected position and releasably secured, or portions can be changed to modify the appearance of the structure. One aspect of the invention provides an accessible compartment in the structure to retain objects such as wires or other conduits, and allows for attaching selected objects to the structure.
    Type: Application
    Filed: December 2, 2005
    Publication date: June 22, 2006
    Inventors: Michael Rowley, David Kurth
  • Publication number: 20060121109
    Abstract: The present invention provides solid dosage formulations of benzoxazole-containing ER?-selective ligands, and processes for their manufacture, more particularly to novel formulations, and processes for their manufacture, that contain the ER?-selective ligand, ERB-041.
    Type: Application
    Filed: November 30, 2005
    Publication date: June 8, 2006
    Applicant: Wyeth
    Inventors: Michael Rowley, Angela Potts, Christopher Wilson, Marc Tesconi, Mannching Ku
  • Publication number: 20060100262
    Abstract: The present invention relates to tetracyclic indole compounds of formula (I): wherein R1, R2, A, Ar, W, X, Y and Z are defined herein, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising them, and their use for the treatment or prevention of infection by hepatitis C virus.
    Type: Application
    Filed: October 25, 2005
    Publication date: May 11, 2006
    Inventors: Immacolata Conte, Caterina Ercolani, Frank Narjes, Marco Pompei, Michael Rowley, Ian Stansfield
  • Publication number: 20060089906
    Abstract: A method for processing a payment transaction between a buyer and a seller over a network using a payment manager is provided. The payment manager manages a plurality of buyer and seller accounts, each account having an account id associated with it. The payment manager receives payment authorization requests for payment transactions, including a payment amount and an identification of a seller. The buyer provides an account id and a location identification to the payment manager, so that the payment manager may determine whether the buyer is communicating over a secure network. If buyer communicates over a secure network, the payment manager requests that the buyer provides a security code to confirm the transaction. If the location identification indicates that the buyer communicates over an insecure network, the payment manager requesting that the buyer answers at least one security question to confirm the transaction.
    Type: Application
    Filed: October 21, 2004
    Publication date: April 27, 2006
    Inventor: Michael Rowley
  • Patent number: 7032891
    Abstract: An improved method and apparatus for fencing and other outdoor structures that allow the structure to be changed or adjusted to modify the function, use or appearance of the structure. The structure can be adjusted into a selected position and releasably secured, or portions can be changed to modify the appearance of the structure. One aspect of the invention provides an accessible compartment in the structure to retain objects such as wires or other conduits, and allows for attaching selected objects to the structure.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: April 25, 2006
    Assignee: On The Fence Technologies, LLC Corporation
    Inventors: Michael Rowley, David Kurth
  • Publication number: 20060046985
    Abstract: Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds of Formula (A): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein n is an integer equal to zero, 1, 2 or 3, and R1, R3, R4, R12, R14, R16, R30, R32, R34 and R36 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: December 18, 2003
    Publication date: March 2, 2006
    Inventors: Benedetta Crescenzi, Olaf Kinzel, Ester Muraglia, Federica Orvieto, Giovanna Pescatore, Michael Rowley, Vincenzo Summa
  • Publication number: 20050136109
    Abstract: This invention relates to an extended release tableted dosage formulation of the antidepressant venlafaxine hydrochloride or an optical form thereof having improved bioavailability.
    Type: Application
    Filed: October 13, 2004
    Publication date: June 23, 2005
    Applicant: Wyeth
    Inventors: Michael Rowley, Angela Potts, Edward Sims
  • Publication number: 20050131740
    Abstract: The present invention provides a system and method for controlling home health care services while improving the consistency and reliability of such services. The present invention also improves the productivity of the caregivers so that costs are reduced and care is improved. Such improvements reduce costs and provide more time with the patient. Indirect costs are also reduced because a more reliable home health care service allows a greater proportion of patients to be treated in their homes at a much lower cost than if they were still receiving inpatient services. During an emergency event, emergency responders have the ability to identify patients most at risk based on proximity to the event and based on the patient's medical condition.
    Type: Application
    Filed: December 7, 2004
    Publication date: June 16, 2005
    Applicant: GeoAge, Incorporated
    Inventors: Donald Massenzio, Michael Rowley, Mark Gintis, Jeffrey Arnold
  • Patent number: 6872731
    Abstract: A class of 3-phenylimidazo[1,2-a]pyridine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH-linkage, are selective ligands for GABAA receptors, in particular having high affinity for the ?2 and/or ?3 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: March 29, 2005
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: James Michael Crawforth, Simon Charles Goodacre, Timothy Harrison, David James Hallett, Andrew Pate Owens, Michael Rowley, Martin Richard Teall
  • Publication number: 20050025774
    Abstract: N-substituted 5-hydroxypyrimidin-6-one-4-carboxamides of formula (I): are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein R1, R2, R3 and R4 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
    Type: Application
    Filed: October 21, 2002
    Publication date: February 3, 2005
    Inventors: Benedetta Crescenzi, Cristina Gardelli, Ester Muraglia, Federica Orvieto, Paola Pace, Giovanna Pescatore, Alessia Petrovich, Marco Poma, Michael Rowley, Rita Scarpelli, Vincenzo Summa, Emanuela Nizi
  • Publication number: 20040140462
    Abstract: An improved method and apparatus for fencing and other outdoor stuctures that allow the structure to be changed or adjusted to modify the function, use or appearance of the structure. The structure can be adjusted into a selected position and releasably secured, or portions can be changed to modify the appearance of the structure. One aspect of the invention provides an accessible compartment in the structure to retain objects such as wires or other conduits, and allows for attaching selected objects to the structure.
    Type: Application
    Filed: January 21, 2003
    Publication date: July 22, 2004
    Applicant: On the Fence Technologies, LLC
    Inventors: Michael Rowley, David Kurth
  • Patent number: 6723735
    Abstract: The present invention is directed to 3-phenylimidazol[4,5-b]pyridine derivatives, that are selective ligands for GABAA receptors. These compounds are useful in the treatment and prevention of disorders of the central nervous system, including anxiety and convulsions.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: April 20, 2004
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: David James Hallett, Michael Rowley
  • Publication number: 20040068509
    Abstract: A method for processing data. Meta-data descriptors (15, 18) are defined to describe the data either by the user (17) or automatically using a meta-data connector (16). A meta-data descriptor describes the structure of data including field names (1, 4). A meta-data connector describes how to access the data. Different types of meta-data connectors (10, 11, 12) exist for different types of data such as JDBC and XML. An interactive user application (23) is utilised to facilitate the definition of a process. A process consists of certain operations (7) in relation to meta-data descriptors (2, 5) such as transformation of data from one field name to another. A component (8, 26) is provided to process data in accordance with the defined process. A computer system and software for implementing the method is also disclosed.
    Type: Application
    Filed: July 21, 2003
    Publication date: April 8, 2004
    Inventors: Peter William Garden, Darren Michael Rowley, Anthony Jason Nigro
  • Patent number: 6608062
    Abstract: A class of substituted 1,2,4-triazolo[4,3-]pyridazine derivatives, possessing an optionally substituted cycloalkyl, phenyl or heteroaryl substituent at the 3-position, a substituted alkoxy moiety at the 6-position, and an optionally substituted bicycloalkyl ring system at the 7-position, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: August 19, 2003
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: William Robert Carling, Alexander Richard Guiblin, Kevin William Moore, Christopher Richard Moyes, Michael Rowley, Leslie Joseph Street
  • Publication number: 20020188000
    Abstract: A class of 3-phenylimidazo[1,2-a]pyridine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a —NH— linkage, are selective ligands for GABAA receptors, in particular having high affinity for the &agr;2 and/or &agr;3 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of disorders of the central nervous system, including anxiety and convulsions.
    Type: Application
    Filed: May 23, 2002
    Publication date: December 12, 2002
    Inventors: James Michael Crawforth, Simon Charles Goodacre, Timothy Harrison, David James Hallett, Andrew Pate Owens, Michael Rowley, Martin Richard Teall
  • Patent number: 6486153
    Abstract: A class of tryptamine analogues bearing an optionally substituted phenyl nucleus at the 2-position are selective antagonists of the human 5-HT2A receptor and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of adverse neurological conditions, including psychotic disorders such as schizophrenia.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: November 26, 2002
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: Jose Luis Castro Pineiro, Steven Michael Hutchins, Stephen John Lewis, Michael Rowley, Adrian Leonard Smith, Graeme Irvine Stevenson
  • Patent number: 6479480
    Abstract: Compounds according to Formula (I) or a salt thereof are selective antagonists of the human 5-HT2A receptor useful for treatment of adverse conditions of the central nervous system:
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: November 12, 2002
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: Christopher Richard Moyes, Michael Rowley
  • Patent number: 6352994
    Abstract: Compounds according to Formula (I) or a salt thereof are selective ligands for GABAA receptors useful for treatment of disorders of the central nervous system:
    Type: Grant
    Filed: January 4, 2001
    Date of Patent: March 5, 2002
    Assignee: Merck Sharp & Dohme Limited
    Inventors: Ian James Collins, Stephen Robert Fletcher, Timothy Harrison, Paul David Leeson, Christopher Richard Moyes, Alan John Nadin, Michael Rowley, Timothy Jason Sparey, Martin Richard Teall
  • Patent number: 6337331
    Abstract: Substituted or 6,7-ring fused 1,2,3-triazolo[1,5-&agr;]-pyrimidine derivatives are selective ligands for GABAA receptors useful in the treatment of disorders of the central nervous system, including anxiety and convulsions.
    Type: Grant
    Filed: November 8, 2000
    Date of Patent: January 8, 2002
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: Howard Barff Broughton, Jose Luis Castro Pineiro, Ian James Collins, Karl Richard Gibson, Michael Rowley, Leslie Joseph Street